Global Point-of-Care or Rapid Testing Market Research Report 2021

Publisher Name :
Date: 04-Mar-2021
No. of pages: 132
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Blood Glucose Testing

- Infectious Diseases Testing

- Cardiac Markers Testing

- Coagulation Testing

- Pregnancy and Fertility Testing

- Blood Gas/Electrolytes Testing

- Urinalysis Testing

- Others

Segment by Application

- Clinics

- Hospitals

- Laboratory

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Roche

- Abbott

- Johnson & Johnson

- Siemens Healthcare

- Danaher

- Ascensia

- Bio-Rad Laboratories

- BioMerieux

- ARKRAY

- Nova Biomedical

- Trividia Health

- Quidel

- Accriva

- OraSure Technologies

- Helena Laboratories

- A. Menarini Diagnostics

- Abaxis (Zoetis)

- Ortho Clinical Diagnostics

- Phamatech

- Chembio Diagnostics

- Sinocare

- Wondfo

- Yuwell

- Runbio

- KHB

- Wuhan EasyDiagnosis Biomedicine

- DAAN GENE

Global Point-of-Care or Rapid Testing Market Research Report 2021

Table of Contents
1 Point-of-Care or Rapid Testing Market Overview
1.1 Product Overview and Scope of Point-of-Care or Rapid Testing
1.2 Point-of-Care or Rapid Testing Segment by Type
1.2.1 Global Point-of-Care or Rapid Testing Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Urinalysis Testing
1.2.9 Others
1.3 Point-of-Care or Rapid Testing Segment by Application
1.3.1 Point-of-Care or Rapid Testing Sales Comparison by Application: (2021-2027)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Global Point-of-Care or Rapid Testing Market Size Estimates and Forecasts
1.4.1 Global Point-of-Care or Rapid Testing Revenue 2016-2027
1.4.2 Global Point-of-Care or Rapid Testing Sales 2016-2027
1.4.3 Point-of-Care or Rapid Testing Market Size by Region: 2016 Versus 2021 Versus 2027
2 Point-of-Care or Rapid Testing Market Competition by Manufacturers
2.1 Global Point-of-Care or Rapid Testing Sales Market Share by Manufacturers (2016-2021)
2.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Point-of-Care or Rapid Testing Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Point-of-Care or Rapid Testing Manufacturing Sites, Area Served, Product Type
2.5 Point-of-Care or Rapid Testing Market Competitive Situation and Trends
2.5.1 Point-of-Care or Rapid Testing Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Point-of-Care or Rapid Testing Players Market Share by Revenue
2.5.3 Global Point-of-Care or Rapid Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Point-of-Care or Rapid Testing Retrospective Market Scenario by Region
3.1 Global Point-of-Care or Rapid Testing Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Point-of-Care or Rapid Testing Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Point-of-Care or Rapid Testing Market Facts & Figures by Country
3.3.1 North America Point-of-Care or Rapid Testing Sales by Country
3.3.2 North America Point-of-Care or Rapid Testing Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Point-of-Care or Rapid Testing Market Facts & Figures by Country
3.4.1 Europe Point-of-Care or Rapid Testing Sales by Country
3.4.2 Europe Point-of-Care or Rapid Testing Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Point-of-Care or Rapid Testing Market Facts & Figures by Region
3.5.1 Asia Pacific Point-of-Care or Rapid Testing Sales by Region
3.5.2 Asia Pacific Point-of-Care or Rapid Testing Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Point-of-Care or Rapid Testing Market Facts & Figures by Country
3.6.1 Latin America Point-of-Care or Rapid Testing Sales by Country
3.6.2 Latin America Point-of-Care or Rapid Testing Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Point-of-Care or Rapid Testing Market Facts & Figures by Country
3.7.1 Middle East and Africa Point-of-Care or Rapid Testing Sales by Country
3.7.2 Middle East and Africa Point-of-Care or Rapid Testing Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Point-of-Care or Rapid Testing Historic Market Analysis by Type
4.1 Global Point-of-Care or Rapid Testing Sales Market Share by Type (2016-2021)
4.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Type (2016-2021)
4.3 Global Point-of-Care or Rapid Testing Price by Type (2016-2021)
5 Global Point-of-Care or Rapid Testing Historic Market Analysis by Application
5.1 Global Point-of-Care or Rapid Testing Sales Market Share by Application (2016-2021)
5.2 Global Point-of-Care or Rapid Testing Revenue Market Share by Application (2016-2021)
5.3 Global Point-of-Care or Rapid Testing Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abbott Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Corporation Information
6.4.2 Siemens Healthcare Description and Business Overview
6.4.3 Siemens Healthcare Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Siemens Healthcare Product Portfolio
6.4.5 Siemens Healthcare Recent Developments/Updates
6.5 Danaher
6.5.1 Danaher Corporation Information
6.5.2 Danaher Description and Business Overview
6.5.3 Danaher Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Danaher Product Portfolio
6.5.5 Danaher Recent Developments/Updates
6.6 Ascensia
6.6.1 Ascensia Corporation Information
6.6.2 Ascensia Description and Business Overview
6.6.3 Ascensia Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ascensia Product Portfolio
6.6.5 Ascensia Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.6.1 Bio-Rad Laboratories Corporation Information
6.6.2 Bio-Rad Laboratories Description and Business Overview
6.6.3 Bio-Rad Laboratories Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bio-Rad Laboratories Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 BioMerieux
6.8.1 BioMerieux Corporation Information
6.8.2 BioMerieux Description and Business Overview
6.8.3 BioMerieux Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BioMerieux Product Portfolio
6.8.5 BioMerieux Recent Developments/Updates
6.9 ARKRAY
6.9.1 ARKRAY Corporation Information
6.9.2 ARKRAY Description and Business Overview
6.9.3 ARKRAY Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ARKRAY Product Portfolio
6.9.5 ARKRAY Recent Developments/Updates
6.10 Nova Biomedical
6.10.1 Nova Biomedical Corporation Information
6.10.2 Nova Biomedical Description and Business Overview
6.10.3 Nova Biomedical Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Nova Biomedical Product Portfolio
6.10.5 Nova Biomedical Recent Developments/Updates
6.11 Trividia Health
6.11.1 Trividia Health Corporation Information
6.11.2 Trividia Health Point-of-Care or Rapid Testing Description and Business Overview
6.11.3 Trividia Health Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Trividia Health Product Portfolio
6.11.5 Trividia Health Recent Developments/Updates
6.12 Quidel
6.12.1 Quidel Corporation Information
6.12.2 Quidel Point-of-Care or Rapid Testing Description and Business Overview
6.12.3 Quidel Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Quidel Product Portfolio
6.12.5 Quidel Recent Developments/Updates
6.13 Accriva
6.13.1 Accriva Corporation Information
6.13.2 Accriva Point-of-Care or Rapid Testing Description and Business Overview
6.13.3 Accriva Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Accriva Product Portfolio
6.13.5 Accriva Recent Developments/Updates
6.14 OraSure Technologies
6.14.1 OraSure Technologies Corporation Information
6.14.2 OraSure Technologies Point-of-Care or Rapid Testing Description and Business Overview
6.14.3 OraSure Technologies Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.14.4 OraSure Technologies Product Portfolio
6.14.5 OraSure Technologies Recent Developments/Updates
6.15 Helena Laboratories
6.15.1 Helena Laboratories Corporation Information
6.15.2 Helena Laboratories Point-of-Care or Rapid Testing Description and Business Overview
6.15.3 Helena Laboratories Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Helena Laboratories Product Portfolio
6.15.5 Helena Laboratories Recent Developments/Updates
6.16 A. Menarini Diagnostics
6.16.1 A. Menarini Diagnostics Corporation Information
6.16.2 A. Menarini Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
6.16.3 A. Menarini Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.16.4 A. Menarini Diagnostics Product Portfolio
6.16.5 A. Menarini Diagnostics Recent Developments/Updates
6.17 Abaxis (Zoetis)
6.17.1 Abaxis (Zoetis) Corporation Information
6.17.2 Abaxis (Zoetis) Point-of-Care or Rapid Testing Description and Business Overview
6.17.3 Abaxis (Zoetis) Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Abaxis (Zoetis) Product Portfolio
6.17.5 Abaxis (Zoetis) Recent Developments/Updates
6.18 Ortho Clinical Diagnostics
6.18.1 Ortho Clinical Diagnostics Corporation Information
6.18.2 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
6.18.3 Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Ortho Clinical Diagnostics Product Portfolio
6.18.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.19 Phamatech
6.19.1 Phamatech Corporation Information
6.19.2 Phamatech Point-of-Care or Rapid Testing Description and Business Overview
6.19.3 Phamatech Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Phamatech Product Portfolio
6.19.5 Phamatech Recent Developments/Updates
6.20 Chembio Diagnostics
6.20.1 Chembio Diagnostics Corporation Information
6.20.2 Chembio Diagnostics Point-of-Care or Rapid Testing Description and Business Overview
6.20.3 Chembio Diagnostics Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Chembio Diagnostics Product Portfolio
6.20.5 Chembio Diagnostics Recent Developments/Updates
6.21 Sinocare
6.21.1 Sinocare Corporation Information
6.21.2 Sinocare Point-of-Care or Rapid Testing Description and Business Overview
6.21.3 Sinocare Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Sinocare Product Portfolio
6.21.5 Sinocare Recent Developments/Updates
6.22 Wondfo
6.22.1 Wondfo Corporation Information
6.22.2 Wondfo Point-of-Care or Rapid Testing Description and Business Overview
6.22.3 Wondfo Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Wondfo Product Portfolio
6.22.5 Wondfo Recent Developments/Updates
6.23 Yuwell
6.23.1 Yuwell Corporation Information
6.23.2 Yuwell Point-of-Care or Rapid Testing Description and Business Overview
6.23.3 Yuwell Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Yuwell Product Portfolio
6.23.5 Yuwell Recent Developments/Updates
6.24 Runbio
6.24.1 Runbio Corporation Information
6.24.2 Runbio Point-of-Care or Rapid Testing Description and Business Overview
6.24.3 Runbio Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Runbio Product Portfolio
6.24.5 Runbio Recent Developments/Updates
6.25 KHB
6.25.1 KHB Corporation Information
6.25.2 KHB Point-of-Care or Rapid Testing Description and Business Overview
6.25.3 KHB Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.25.4 KHB Product Portfolio
6.25.5 KHB Recent Developments/Updates
6.26 Wuhan EasyDiagnosis Biomedicine
6.26.1 Wuhan EasyDiagnosis Biomedicine Corporation Information
6.26.2 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Description and Business Overview
6.26.3 Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.26.4 Wuhan EasyDiagnosis Biomedicine Product Portfolio
6.26.5 Wuhan EasyDiagnosis Biomedicine Recent Developments/Updates
6.27 DAAN GENE
6.27.1 DAAN GENE Corporation Information
6.27.2 DAAN GENE Point-of-Care or Rapid Testing Description and Business Overview
6.27.3 DAAN GENE Point-of-Care or Rapid Testing Sales, Revenue and Gross Margin (2016-2021)
6.27.4 DAAN GENE Product Portfolio
6.27.5 DAAN GENE Recent Developments/Updates
7 Point-of-Care or Rapid Testing Manufacturing Cost Analysis
7.1 Point-of-Care or Rapid Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Point-of-Care or Rapid Testing
7.4 Point-of-Care or Rapid Testing Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Point-of-Care or Rapid Testing Distributors List
8.3 Point-of-Care or Rapid Testing Customers
9 Point-of-Care or Rapid Testing Market Dynamics
9.1 Point-of-Care or Rapid Testing Industry Trends
9.2 Point-of-Care or Rapid Testing Growth Drivers
9.3 Point-of-Care or Rapid Testing Market Challenges
9.4 Point-of-Care or Rapid Testing Market Restraints
10 Global Market Forecast
10.1 Point-of-Care or Rapid Testing Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Type (2022-2027)
10.2 Point-of-Care or Rapid Testing Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Application (2022-2027)
10.3 Point-of-Care or Rapid Testing Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Point-of-Care or Rapid Testing by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Point-of-Care or Rapid Testing by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Point-of-Care or Rapid Testing Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Point-of-Care or Rapid Testing Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Point-of-Care or Rapid Testing Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Point-of-Care or Rapid Testing Covered in This Study
Table 5. Global Point-of-Care or Rapid Testing Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Point-of-Care or Rapid Testing Sales Share by Manufacturers (2016-2021)
Table 7. Global Point-of-Care or Rapid Testing Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Point-of-Care or Rapid Testing Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Point-of-Care or Rapid Testing Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Point-of-Care or Rapid Testing Manufacturing Sites and Area Served
Table 11. Manufacturers Point-of-Care or Rapid Testing Product Type
Table 12. Global Point-of-Care or Rapid Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Point-of-Care or Rapid Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care or Rapid Testing as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Point-of-Care or Rapid Testing Sales by Region (2016-2021) & (K Units)
Table 16. Global Point-of-Care or Rapid Testing Sales Market Share by Region (2016-2021)
Table 17. Global Point-of-Care or Rapid Testing Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Point-of-Care or Rapid Testing Sales by Country (2016-2021) & (K Units)
Table 19. North America Point-of-Care or Rapid Testing Sales Market Share by Country (2016-2021)
Table 20. North America Point-of-Care or Rapid Testing Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Point-of-Care or Rapid Testing Revenue Market Share by Country (2016-2021)
Table 22. Europe Point-of-Care or Rapid Testing Sales by Country (2016-2021) & (K Units)
Table 23. Europe Point-of-Care or Rapid Testing Sales Market Share by Country (2016-2021)
Table 24. Europe Point-of-Care or Rapid Testing Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Point-of-Care or Rapid Testing Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Point-of-Care or Rapid Testing Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Point-of-Care or Rapid Testing Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Point-of-Care or Rapid Testing Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Point-of-Care or Rapid Testing Revenue Market Share by Region (2016-2021)
Table 30. Latin America Point-of-Care or Rapid Testing Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Point-of-Care or Rapid Testing Sales Market Share by Country (2016-2021)
Table 32. Latin America Point-of-Care or Rapid Testing Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Point-of-Care or Rapid Testing Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Point-of-Care or Rapid Testing Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Point-of-Care or Rapid Testing Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Point-of-Care or Rapid Testing Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Point-of-Care or Rapid Testing Revenue Market Share by Country (2016-2021)
Table 38. Global Point-of-Care or Rapid Testing Sales (K Units) by Type (2016-2021)
Table 39. Global Point-of-Care or Rapid Testing Sales Market Share by Type (2016-2021)
Table 40. Global Point-of-Care or Rapid Testing Revenue (Million US$) by Type (2016-2021)
Table 41. Global Point-of-Care or Rapid Testing Revenue Share by Type (2016-2021)
Table 42. Global Point-of-Care or Rapid Testing Price (USD/Unit) by Type (2016-2021)
Table 43. Global Point-of-Care or Rapid Testing Sales (K Units) by Application (2016-2021)
Table 44. Global Point-of-Care or Rapid Testing Sales Market Share by Application (2016-2021)
Table 45. Global Point-of-Care or Rapid Testing Revenue (Million US$) by Application (2016-2021)
Table 46. Global Point-of-Care or Rapid Testing Revenue Share by Application (2016-2021)
Table 47. Global Point-of-Care or Rapid Testing Price (USD/Unit) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Roche Point-of-Care or Rapid Testing Product
Table 52. Roche Recent Developments/Updates
Table 53. Abbott Corporation Information
Table 54. Abbott Description and Business Overview
Table 55. Abbott Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Abbott Point-of-Care or Rapid Testing Product
Table 57. Abbott Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Point-of-Care or Rapid Testing Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Siemens Healthcare Corporation Information
Table 64. Siemens Healthcare Description and Business Overview
Table 65. Siemens Healthcare Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Siemens Healthcare Point-of-Care or Rapid Testing Product
Table 67. Siemens Healthcare Recent Developments/Updates
Table 68. Danaher Corporation Information
Table 69. Danaher Description and Business Overview
Table 70. Danaher Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Danaher Point-of-Care or Rapid Testing Product
Table 72. Danaher Recent Developments/Updates
Table 73. Ascensia Corporation Information
Table 74. Ascensia Description and Business Overview
Table 75. Ascensia Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Ascensia Point-of-Care or Rapid Testing Product
Table 77. Ascensia Recent Developments/Updates
Table 78. Bio-Rad Laboratories Corporation Information
Table 79. Bio-Rad Laboratories Description and Business Overview
Table 80. Bio-Rad Laboratories Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Bio-Rad Laboratories Point-of-Care or Rapid Testing Product
Table 82. Bio-Rad Laboratories Recent Developments/Updates
Table 83. BioMerieux Corporation Information
Table 84. BioMerieux Description and Business Overview
Table 85. BioMerieux Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. BioMerieux Point-of-Care or Rapid Testing Product
Table 87. BioMerieux Recent Developments/Updates
Table 88. ARKRAY Corporation Information
Table 89. ARKRAY Description and Business Overview
Table 90. ARKRAY Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. ARKRAY Point-of-Care or Rapid Testing Product
Table 92. ARKRAY Recent Developments/Updates
Table 93. Nova Biomedical Corporation Information
Table 94. Nova Biomedical Description and Business Overview
Table 95. Nova Biomedical Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Nova Biomedical Point-of-Care or Rapid Testing Product
Table 97. Nova Biomedical Recent Developments/Updates
Table 98. Trividia Health Corporation Information
Table 99. Trividia Health Description and Business Overview
Table 100. Trividia Health Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Trividia Health Point-of-Care or Rapid Testing Product
Table 102. Trividia Health Recent Developments/Updates
Table 103. Quidel Corporation Information
Table 104. Quidel Description and Business Overview
Table 105. Quidel Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Quidel Point-of-Care or Rapid Testing Product
Table 107. Quidel Recent Developments/Updates
Table 108. Accriva Corporation Information
Table 109. Accriva Description and Business Overview
Table 110. Accriva Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Accriva Point-of-Care or Rapid Testing Product
Table 112. Accriva Recent Developments/Updates
Table 113. OraSure Technologies Corporation Information
Table 114. OraSure Technologies Description and Business Overview
Table 115. OraSure Technologies Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. OraSure Technologies Point-of-Care or Rapid Testing Product
Table 117. OraSure Technologies Recent Developments/Updates
Table 118. Helena Laboratories Corporation Information
Table 119. Helena Laboratories Description and Business Overview
Table 120. Helena Laboratories Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Helena Laboratories Point-of-Care or Rapid Testing Product
Table 122. Helena Laboratories Recent Developments/Updates
Table 123. A. Menarini Diagnostics Corporation Information
Table 124. A. Menarini Diagnostics Description and Business Overview
Table 125. A. Menarini Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. A. Menarini Diagnostics Point-of-Care or Rapid Testing Product
Table 127. A. Menarini Diagnostics Recent Developments/Updates
Table 128. Abaxis (Zoetis) Corporation Information
Table 129. Abaxis (Zoetis) Description and Business Overview
Table 130. Abaxis (Zoetis) Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Abaxis (Zoetis) Point-of-Care or Rapid Testing Product
Table 132. Abaxis (Zoetis) Recent Developments/Updates
Table 133. Ortho Clinical Diagnostics Corporation Information
Table 134. Ortho Clinical Diagnostics Description and Business Overview
Table 135. Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Ortho Clinical Diagnostics Point-of-Care or Rapid Testing Product
Table 137. Ortho Clinical Diagnostics Recent Developments/Updates
Table 138. Phamatech Corporation Information
Table 139. Phamatech Description and Business Overview
Table 140. Phamatech Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Phamatech Point-of-Care or Rapid Testing Product
Table 142. Phamatech Recent Developments/Updates
Table 143. Chembio Diagnostics Corporation Information
Table 144. Chembio Diagnostics Description and Business Overview
Table 145. Chembio Diagnostics Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Chembio Diagnostics Point-of-Care or Rapid Testing Product
Table 147. Chembio Diagnostics Recent Developments/Updates
Table 148. Sinocare Corporation Information
Table 149. Sinocare Description and Business Overview
Table 150. Sinocare Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Sinocare Point-of-Care or Rapid Testing Product
Table 152. Sinocare Recent Developments/Updates
Table 153. Wondfo Corporation Information
Table 154. Wondfo Description and Business Overview
Table 155. Wondfo Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Wondfo Point-of-Care or Rapid Testing Product
Table 157. Wondfo Recent Developments/Updates
Table 158. Yuwell Corporation Information
Table 159. Yuwell Description and Business Overview
Table 160. Yuwell Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 161. Yuwell Point-of-Care or Rapid Testing Product
Table 162. Yuwell Recent Developments/Updates
Table 163. Runbio Corporation Information
Table 164. Runbio Description and Business Overview
Table 165. Runbio Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 166. Runbio Point-of-Care or Rapid Testing Product
Table 167. Runbio Recent Developments/Updates
Table 168. KHB Corporation Information
Table 169. KHB Description and Business Overview
Table 170. KHB Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 171. KHB Point-of-Care or Rapid Testing Product
Table 172. KHB Recent Developments/Updates
Table 173. Wuhan EasyDiagnosis Biomedicine Corporation Information
Table 174. Wuhan EasyDiagnosis Biomedicine Description and Business Overview
Table 175. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 176. Wuhan EasyDiagnosis Biomedicine Point-of-Care or Rapid Testing Product
Table 177. Wuhan EasyDiagnosis Biomedicine Recent Developments/Updates
Table 178. DAAN GENE Corporation Information
Table 179. DAAN GENE Description and Business Overview
Table 180. DAAN GENE Point-of-Care or Rapid Testing Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 181. DAAN GENE Point-of-Care or Rapid Testing Product
Table 182. DAAN GENE Recent Developments/Updates
Table 183. Production Base and Market Concentration Rate of Raw Material
Table 184. Key Suppliers of Raw Materials
Table 185. Point-of-Care or Rapid Testing Distributors List
Table 186. Point-of-Care or Rapid Testing Customers List
Table 187. Point-of-Care or Rapid Testing Market Trends
Table 188. Point-of-Care or Rapid Testing Growth Drivers
Table 189. Point-of-Care or Rapid Testing Market Restraints
Table 190. Global Point-of-Care or Rapid Testing Sales Forecast by Type (2022-2027) & (K Units)
Table 191. Global Point-of-Care or Rapid Testing Sales Market Share Forecast by Type (2022-2027)
Table 192.
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs